logo
AAT Bioquest

PH domain leucine-rich repeat-containing protein phosphatase 2 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
SodiumIC5033000.0 [1]
3-(2-PYRIDYL)-5,6-bis-[2-(5-FURYL-SULFONIC ACID)]-1,2,4-TRIAZINEIC5010000.0 [1]
3,20-Dioxopregn-4-en-21-yl 4-bromobenzenesulfonateIC5011000.0 [1]
1-Amino-9,10-dioxo-4-(3-sulfamoylphenylamino)-9,10-dihydroanthracene-2-sulfonic acidIC504000.0 [1]
9-Benzyl-6-(benzylthio)-9H-purin-2-amineIC5040000.0 [1]
4-Nitrophenylbis[4-(dimethylamino)phenyl]methaneIC5010000.0 [1]
1-((4-Methoxyanilino)methyl)-2-naphtholIC504000.0 [1]
2-(4,5,6-Trihydroxy-3-oxo-3H-xanthen-9-yl)-cyclohexane-1-carboxylic acidIC5010000.0 [1]
2-Anthracenesulfonic acid, 4-[[4-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxo-IC5041000.0 [1]
(Dimethylamino)ethyl p-aminobenzoateIC505000.0 [1]
9H-Fluoren-9-one, 2,3-dinitro-IC5010000.0 [1]
SalazosulfamideIC5075000.0 [1]
4-((3-Hydroxy-2-pyridinyl)diazenyl)benzenesulfonamideIC507000.0 [1]
4-((6-Chloro-2-methoxy-9-acridinyl)amino)-2-hydroxybenzoic acidIC5035000.0 [1]
3-Methyl-5-((4-((4-sulphophenyl)azo)phenyl)azo)salicylic acidIC5083000.0 [1]
5-[[4-[4-[(7-Anilino-1-hydroxy-3-methylsulfonylnaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]-2-hydroxybenzoic acidIC5049000.0 [1]
5-[[4-[4-[(6-Anilino-1-hydroxy-3-methylsulfonylnaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]-2-hydroxybenzoic acidIC5052000.0 [1]
5-Amino-4-hydroxy-3-[[4-[4-[(2-hydroxy-8-sulfonaphthalen-1-yl)diazenyl]phenyl]sulfonylphenyl]diazenyl]naphthalene-2,7-disulfonic acidIC5080000.0 [1]
Blue RXIC5058000.0 [1]
SalazosulfathiazoleIC5049000.0 [1]
7-Amino-4-hydroxy-3-[[4-[4-[(1-hydroxy-4-sulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]naphthalene-2-sulfonic acidIC5039000.0 [1]
2-Hydroxy-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]naphthalene-1-carboxylic acidIC5034000.0 [1]
2-Hydroxy-3-[[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]diazenyl]naphthalene-1-carboxylic acidIC5030000.0 [1]
N,N'-Di(1H-indazol-6-yl)thioureaIC505000.0 [1]
4-(6-Chloro-2-methoxyacridin-9-ylamino)benzoic acidIC5045000.0 [1]
6-Methoxy-N-(2-(2-piperidinyl)ethyl)-8-quinolinamineIC504000.0 [1]
5-((E)-(4-((E)-(2,4-Diamino-5-methylphenyl)diazenyl)phenyl)diazenyl)-2-hydroxybenzoic acidIC503750.0 [1]
5-[[4-[4-[[2,4-Diamino-5-[(4-sulfophenyl)diazenyl]phenyl]diazenyl]phenyl]phenyl]diazenyl]-2-hydroxybenzoic acidIC5020000.0 [1]
2-Hydroxy-5-((E)-(2-methoxy-4-((E)-(4-sulfophenyl)diazenyl)phenyl)diazenyl)benzoic acidIC5032000.0 [1]
5-[[4-[[2,4-Diamino-5-methyl-3-[(4-methyl-2-sulfophenyl)diazenyl]phenyl]diazenyl]phenyl]diazenyl]-2-hydroxybenzoic acidIC5010000.0 [1]
8-Amino-5-[[4-[4-[(4-amino-6-methylsulfonylnaphthalen-1-yl)diazenyl]phenyl]phenyl]diazenyl]naphthalene-2-sulfonic acidIC5015000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ PH domain leucine-rich repeat-containing protein phosphatase 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.10 May2024https://www.aatbio.com/data-sets/ph-domain-leucine-rich-repeat-containing-protein-phosphatase-2-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024May 10). Quest Database™ PH domain leucine-rich repeat-containing protein phosphatase 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/ph-domain-leucine-rich-repeat-containing-protein-phosphatase-2-inhibitors-ic50-ki.
BibTeXEndNoteRefMan